Our Research

Please use selectors to filter reports

September 11, 2024
Newsletters
Newsletters & Thematics

Movers & Shakers: Pharma & Biotech

In this edition of Movers & Shakers for Pharma & Biotech we take a look at 5 companies whose share prices rallied in August...
Request professional access
September 6, 2024
Newsletters
Newsletters & Thematics

IIR LMI Monthly Update

In this edition of the IIR LMI Monthly Update we take a look at the key news items and announcements in August as well as include the key data points as at 31 July 2024....
Request professional access
September 4, 2024
Listed Managed Investment

Perpetual Credit Income Trust (ASX: PCI) Review

Perpetual Credit Income Trust (ASX: PCI) is a listed investment trust (LIT) designed to provide investors with regular monthly income through an actively managed portfolio of diversified credit exposures by asset type, issuers,...
Request professional access
August 16, 2024
Listed Managed Investment

Ophir High Conviction Fund (ASX: OPH) Review

We have completed a review of the Ophir High Conviction Fund (ASX: OPH). OPH is a listed investment trust (LIT) that provides exposure to a concentrated portfolio of mid and small cap Australian and New Zealand listed securities. ...
Request professional access
August 14, 2024
Equity Research Coverage
U.S. Equities

Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) Update Report

We have completed an update report for Acurx following the release of the June quarterly results and business update on 9 August 2024. ...
Request professional access
August 11, 2024
Newsletters
Newsletters & Thematics

Movers & Shakers: Pharma & Biotech

In this edition of the Movers & Shakers for Pharma & Biotech we take a look at five ASX-listed companies whose share prices rallied in July....
Request professional access
August 8, 2024
Newsletters
Newsletters & Thematics

IIR LMI Monthly Update

In this edition of the IIR LMI Monthly Update we take a look at the key news for July as well as the key data points as at 30 June 2024. We also take a look at the FY24 results that have been released already....
Request professional access
August 5, 2024
Equity Research Coverage

Updated Coverage of Matsa Resources (ASX: MAT)

We have updated our research coverage of Matsa Resources (ASX: MAT). Matsa has a gold Resource of 936Koz at 2.5g/t and is close to producing from its Devon gold mine, and is finalising the mining and processing contracts and obtaining funding. Devon ...
Request professional access
July 29, 2024
Equity Research Coverage
U.S. Equities

Anavex Life Sciences Corporation (NASDAQ: AVXL) – Initiating Coverage

IIR has assigned Anavex a price target of $40.89 per share ($30.43 per share on a fully diluted basis and $33.93 using the treasury stock method)....
Request professional access